Individual SGLT-2 Inhibitors and Cardiovascular and Safety Outcomes

This comparative effectiveness research study uses target trial emulation to examine the effectiveness of individual sodium-glucose cotransporter 2 (SGLT-2) inhibitors canagliflozin or dapagliflozin compared with empagliflozin using a composite outcome.

from JAMA Internal Medicine Online First https://ift.tt/Vl4zohC